Sort
261,768 grants matching “gene therapy”
Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Phase 3 Multi-Center, Randomized, Double-Blind, Sham-Controlled Trial
$2,439,584Parambir Singh Dulai · Northwestern University At Chicago · U01 · FY2023 · DK
Comparative Genomics of Longevity
$2,439,250Vera Gorbunova · University Of Rochester · P01 · FY2019 · AG
WEILL CORNELL PROGRAM OF EXCELLENCE IN GENE THERAPY
$2,439,199Weill Medical College Of Cornell Univ · U01 · FY2002 · HL
Mayo Clinic Breast Cancer SPORE
$2,438,534Matthew Philip Goetz · Mayo Clinic Rochester · P50 · FY2017 · CA
University of Texas MD Anderson SPORE in Ovarian Cancer
$2,438,308University Of Texas Md Anderson Can Ctr · P50 · FY2005 · CA
SPORE: Targeted Therapies for Glioma
$2,438,174Tracy T Batchelor · Brigham And Women'S Hospital · P50 · FY2019 · CA
Cell-Type Specific Vulnerability to Tauopathy and Its Prevention in Multiple Models
$2,438,130Einar M Sigurdsson · New York University School Of Medicine · RF1 · FY2021 · NS
Mitochondrial and Metabolic Dysfunction in Age-related Neurodegeneration
$2,437,958Gary E Gibson · Winifred Masterson Burke Med Res Inst · P01 · FY2016 · AG
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)
$2,437,131Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2009 · HL
Exploration of the TranslationalTherapeutic Potential of Stem Cell B
$2,437,089Howard Fine · Basic Sciences · Z01 · FY2007 · CA
Brooklyn Women's Interagency HIV Study (WIHS) V
$2,436,591Howard Minkoff · Suny Downstate Medical Center · U01 · FY2017 · AI
Lentiviral Gene Therapy for Sickle Cell Disease and Immunodeficiency Disorders
$2,436,444Brian P Sorrentino · St. Jude Children'S Research Hospital · P01 · FY2011 · HL
Targeting the Epigenetic and Metabolic Control of EBV-Epithelial Cancers
$2,436,054Paul M. Lieberman · Wistar Institute · P01 · FY2023 · CA
SPORE in Prostate Cancer
$2,436,043Howard I Scher · Sloan-Kettering Inst Can Research · P50 · FY2017 · CA
Development and Validation of Therapy for Mucopolysaccharidosis III
$2,435,870Jill Wood · Phoenix Nest, Inc. · U44 · FY2022 · NS
Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors (SOARS-B)
$2,435,695Linmarie Sikich · Univ Of North Carolina Chapel Hill · U01 · FY2013 · HD
Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma
$2,435,478Reynold Alexander Panettieri · Rutgers Biomedical/Health Sciences-Rbhs · P01 · FY2017 · HL
Integrating innate and adaptive pathways in vaccine responses
$2,435,437Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2014 · AI
Adenovirus-vectored nasal anthrax vaccine
$2,435,173Vaxin Inc. · UC1 · FY2005 · AI
Biological Variation in Hemophilia
$2,434,893John S. Lollar · Emory University · U54 · FY2014 · HL
Biological Variation in Hemophilia
$2,434,741John S. Lollar · Emory University · U54 · FY2016 · HL
The Memorial Sloan Kettering Cancer Center SPORE in Pancreas Cancer
$2,434,565Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research · P50 · FY2025 · CA
Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV
$2,433,874Manolis Kellis · Broad Institute, Inc. · U01 · FY2023 · DA
"Genetic and clinical studies of Gaucher disease and other lysosomal disorders"
$2,433,208Ellen Sidransky · National Human Genome Research Institute · ZIA · FY2015 · HG
Role of Macrophages in Impaired Wound Healing in Type 1 Diabetes
$2,432,818Aristidis Veves · Beth Israel Deaconess Medical Center · DP3 · FY2015 · DK